Analogue "vilprafen" - ma ọ bụrụ na ọ bụ?

N'etiti gbaara-adịghị njọ ọgwụ na ọgwụ ọjọọ, "Vilprafen" a maara dị ka ọgwụ nje nke na pharmacological ìgwè nke macrolides, lincosamides na streptogramin. Ọ na-emekarị kenyere Iguzogide nje na-efe efe, nke na-kpatara susceptible microorganisms. Kwuru, mmetụta nke ọgwụ irè ikpe nke akụkụ okuku ume na tract-efe efe na eze na ọnya nke urogenital usoro na dermal na-efe efe nke rọrọ anụ ahụ na anụ ahụ na ureaplasmosis gonorrhea, chlamydia na syphilis mikroplazmoze na yiri efe efe. Analogue "Vilprafen" - nkwadebe "clarithromycin" - na-na-na-eji dị ka onye ọzọ.

pharmacological mmetụta

Vilprafen ma ọ bụ ndị ọzọ okwu - Josamycin elu ọrụ megide intracellular ntule, kama mgbe omume nke erythromycin eguzogide na-adịghị akpata. High ọgwụ ịta na anụ ahụ ọnya nwere a doro anya bactericidal edinam nke enterobacteria na nwere obere mmetụta. Nke a pụtara na afo adịghị agbanwe eke nje osisi.

Kinetics n'ikuku

Iri nnọọ adịghị egbochi bioavailability nke Njirimara nke ọgwụ. n'ihi na ọ na-etinye obi gị dum na-adị mfe na-adịghị adịgide adịgide si eriri afọ tract n'ime n'ọbara. Ugbua a awa ole na ole mgbe ingestion nke ọgwụ "Vilprafen" kacha ọbara ịta na-enweta. Plasma na-edozi na-ekekọta ka ụmụ irighiri dzhosamitsina, isi n'ọrụ mgwa nke ọgwụ, na ya ịta esịmde 15%. Karịsịa elu pasent hụrụ na tonsils na akpa ume, sputum, lacrimal ọmụmụ. The ọgwụ nwere ike akpọkọtara na ọkpukpu, anụ ahụ na secreted na mmiri ara mgbe-agafe site placental mgbochi. Metabolism dzhosamitsina na weakly ifịk metabolites na imeju. Ọgwụgwụ na-abịa site bile. Excretion site na urethra bụ banyere 20%.

Dzhosamitsin - isi akụrụngwa nke ọgwụ "Vilprafen"

Ọ bụ eziokwu na Dzhosamitsin bụ naanị ndị kasị mkpa umi ke mejupụtara nke ọgwụ, ihe analọg nke "vilprafen" adịghị adị.

Ndị isi ihe na ewute ndị mgbe ịzụrụ vilprafen - ọ bụ ezi ihe dị oké ọnụ ọgwụgwọ na-adịru ogologo oge karịa 10 ụbọchị. Daha ya iji nweta a quality mmetụta ga-n'ụzọ zuru ezu ma na-ọgwụ kwa ụbọchị. "Vilprafen" na niile mma reviews banyere ọgwụ nwere nnukwu ezu price, ya mere ndị mmadụ na-mgbe niile na-achọ ihe oké ọnụ ma na-enwe ahụ dị ka ihe ntụnyere. Ụfọdụ ndị ọkachamara nwere ike ikwu dị ka analọg "vilprafen" ọgwụ ọjọọ "Clarithromycin", ma naanị dị ka onye ọzọ.

Chọta analogue "vilprafen" ọtụtụ ndị ọzọ Nkea na ya iji na-adịghị aju ka nwanyị dị ime, ọ ga-eji na ara nne ha, na ọ bụ nchebe maka ụmụaka. Na mara enweghị embryotoxic mmetụta "Vilprafen" ọgwụ na-kenyere, naanị nlezianya tụlee ihe ize ndụ na abamuru nke ọgwụgwọ.

Medicine "Vilprafen" na ya Nchikota na mmanya

The Regulations weghaara ọgwụ, anaghị nwere ihe ọ bụla nke na-egosi na mmanya na-arụsi ọrụ umi mmekọrịta dzhosamitsina. Medicine "Vilprafen" na mmanya - ọjọọ Nchikota. Ezi uche onye na-ekwesịghị ichefu na mmanya na-mgbe na-akpa mmetụta dị njọ n'ahụ imeju - isi ikike maka excretion nke ọgwụ ọjọọ n'ahụ. Ọ na-eche na oké imebi nke imeju ọrụ ga-ịkpalite ọrịa ntutu ịdapụsị eruba nke bile na mmanya oriri bụ nnọọ ekwesighi. Allowable kwa ụbọchị ọnụego nwere ike iru, ma-ọbughi na 200 milligrams nke mmanya na na na-anọghị nke ụba imeju enzymes na plasma.